Call Us: +1 (800) 722-4123 
“Emerald’s DNA is our devotion to fundamental research – it is woven into each of our strategies and championed by every one of our investment professionals.”
Emerald’s DNA – Identifying innovators and disruptors through fundamental, bottom up research. We believe that fundamental, bottom up research can lead to superior active management.
Actively-managed diversified small-cap growth portfolio usually holding approximately 110-120 stocks.
Actively-managed diversified mid-cap growth portfolio usually holding approximately 80-100 stocks.
Actively-managed growth-oriented portfolio holding 55-75 stocks seeking to exploit small and mid-cap market inefficiencies paired with corresponding thematic large-cap names.
Growth-oriented Mutual Fund investing primarily in smaller-sized domestic companies.
Mutual Fund investing primarily in banks and financial services companies.
Mutual Fund investing in small and mid-cap growth companies paired with corresponding thematic large-cap companies.
Actively managed ETF investing primarily in equity securities of life sciences companies.
Fixed income portfolio management tailored to meet short to intermediate term cash and liquidity needs.
“Emerald’s DNA is our devotion to fundamental research – it is woven into each of our strategies and championed by every one of our investment professionals.”
You are now leaving www.teamemerald.com. Follow the link below to learn more about the F/m Emerald Life Sciences Innovation ETF.
You are now leaving www.teamemerald.com. Follow the link below to learn more about the Emerald Growth Fund.
You are now leaving www.teamemerald.com. Follow the link below to learn more about the Emerald Finance and Banking Innovation Fund.
https://www.emeraldmutualfunds.com/emerald-finance-banking-innovation-fund ➜
You are now leaving www.teamemerald.com. Follow the link below to learn more about the Emerald Insights Fund.